Viewing StudyNCT00075374



Ignite Creation Date: 2024-05-05 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00075374
Status: COMPLETED
Last Update Posted: 2014-01-16
First Post: 2004-01-09

Brief Title: Two Regimens of Docetaxel in Treating Patients Who Have Not Received Chemotherapy For Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Organization: Case Comprehensive Cancer Center

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 6
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: